# Study of Single IV Administration of P2G12

> **NCT02923999** · PHASE1 · UNKNOWN · sponsor: **St George's, University of London** · enrollment: 18 (estimated)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** P2G12 Dose Cohort 1
- **DRUG:** P2G12 Dose Cohort 2
- **DRUG:** P2G12 Dose Cohort 3

## Key facts

- **NCT ID:** NCT02923999
- **Lead sponsor:** St George's, University of London
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08
- **Primary completion:** 2020-08
- **Final completion:** 2020-12
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2019-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02923999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02923999, "Study of Single IV Administration of P2G12". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT02923999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*